Bristol Myers Squibb (BMY) Minority Interest (2009 - 2026)

Bristol Myers Squibb (BMY) has reported Minority Interest for 18 consecutive years, with $34.0 million the latest figure, recorded in Q1 2026.

• On a quarterly basis, Minority Interest fell 42.37% year-over-year to $34.0 million in Q1 2026; TTM through Mar 2026 was $34.0 million, a 42.37% decrease from a year earlier, with the FY2025 full-year figure at $33.0 million, down 37.74% from the prior year.
• Minority Interest was $34.0 million for Q1 2026 at Bristol Myers Squibb, up from $33.0 million in the prior quarter.
• Over five years, Minority Interest peaked at $65.0 million in Q1 2022 and troughed at $33.0 million in Q4 2025.
• A 5-year average of $55.0 million and a median of $57.0 million in 2022 frame the typical range for Minority Interest.
• Across the five-year window, Minority Interest advanced 1.72% in 2025 and sank 42.37% in 2026, its largest moves.
• Over 5 years, Minority Interest stood at $57.0 million in 2022, then declined by 3.51% to $55.0 million in 2023, then slipped by 3.64% to $53.0 million in 2024, then sank by 37.74% to $33.0 million in 2025, then increased by 3.03% to $34.0 million in 2026.
• The last three Minority Interest figures came in at $34.0 million (Q1 2026), $33.0 million (Q4 2025), and $48.0 million (Q3 2025), per Business Quant data.